Cetera Investment Advisers
PCVX icon

Cetera Investment Advisers’s Vaxcyte PCVX Stock Holding History

Cetera Investment Advisers’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$602K Buy
10,362
+767
+8% +$41.7K ﹤0.01% 3525
2026
Q1 		$558K Buy
9,595
+1,798
+23% +$97.6K ﹤0.01% 3408
2025
Q4 		$360K Sell
7,797
-701
-8% -$31.4K ﹤0.01% 3728
2025
Q3 		$306K Buy
8,498
+817
+11% +$27.1K ﹤0.01% 3817
2025
Q2 		$250K Buy
7,681
+932
+14% +$30.6K ﹤0.01% 3553
2025
Q1 		$255K Buy
6,749
+1,665
+33% +$133K ﹤0.01% 3406
2024
Q4 		$416K Sell
5,084
-43
-0.8% -$4.27K ﹤0.01% 2826
2024
Q3 		$586K Buy
5,127
+399
+8% +$36K ﹤0.01% 2520
2024
Q2 		$357K Buy
4,728
+248
+6% +$16.9K ﹤0.01% 2877
2024
Q1 		$306K Buy
+4,480
New +$310K ﹤0.01% 3022

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Cetera Investment Advisers's PCVX Position: Q2 2026 in Review

Cetera Investment Advisers increased its Vaxcyte (PCVX) stake by 8% in Q2 2026, buying an estimated $41.7K and bringing the position to 10,362 shares worth $602K. The position accounts for ﹤0.01% of the portfolio, ranked #3525.

Cetera Investment Advisers first reported a position in PCVX in Q1 2024 and has held it in 10 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Cetera Investment Advisers held 10,362 shares of Vaxcyte worth $602K as of Q2 2026.
  • Cetera Investment Advisers bought 767 Vaxcyte shares in Q2 2026, an estimated $41.7K.
  • Vaxcyte made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3525 holding.
  • Cetera Investment Advisers first reported a position in Vaxcyte in Q1 2024 and has held it in 10 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.